Abbott Abbott Lowers FY21 Guidance as It Sees Sharp Decline in COVID-19 Test Revenue The firm's CEO said that despite the decline, its base business is returning to normal and has "strong momentum." Abbott Q1 Diagnostics Revenues More Than Double on COVID-19 Testing The firm's growth was driven largely by demand for its rapid and laboratory-based COVID-19 tests, which totaled $2.2 billion in revenues for the quarter. Abbott Forms Global Coalition to Monitor, Prevent Future Pandemics The program will identify new pathogens, analyze potential risk level, develop and deploy new diagnostic testing, and assess the public health impact. Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections The company also said that a previously granted EUA for its Alinity m SARS-CoV-2 assay has been expanded to include asymptomatic individuals and pooled testing. WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance The findings stem from a recent meeting of a WHO Guideline Development Group convened to address challenges with TB diagnosis and related drug-resistance. Jan 27, 2021 Abbott Q4 Diagnostics Revenues up 111 Percent, FY20 Revenues up 9 Percent Nov 13, 2020 Abbott Enters $5B Credit Agreement Oct 21, 2020 Abbott Q3 Diagnostics Revenues Increase 38 Percent Oct 7, 2020 Abbott ID Now Study Data Confirms Test Sensitivity and Specificity Sep 21, 2020 FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Jul 21, 2020 AdvaMed Partners With Dx Companies to Create National COVID-19 Supply Registry Jul 17, 2020 Weathering COVID-19 Pandemic, Abbott Beats Analyst Q2 Expectations on Coronavirus Testing Demand Premium Jul 16, 2020 Abbott Q2 Diagnostics Revenues Rise 5 Percent, MDx Revenues Skyrocket Jun 12, 2020 In Brief This Week: Guardant Health, Illumina, Twist Bioscience, Hologic, InCellDx, More Jun 1, 2020 Sema4 Forms Coronavirus Testing Alliance With Connecticut May 28, 2020 AMP SARS-CoV-2 Molecular Dx Survey Shows Supply Chain Issues Hampered Ramp Up of Testing May 26, 2020 Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer May 26, 2020 With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks Premium May 15, 2020 FDA, Abbott Address Accuracy Concerns About SARS-CoV-2 POC MDx Test May 14, 2020 New Study Finds Abbott's ID Now SARS-CoV-2 Test Misses Sensitivity Mark May 12, 2020 Abbott Nabs FDA Emergency Use Authorization for SARS-CoV-2 Test on High-Throughput System Apr 16, 2020 Abbott Plans Additional Tests, Manufacturing Increases to Meet SARS-CoV-2 Demand Apr 16, 2020 Abbott Q1 Diagnostics Revenues Down 1 Percent as Overall Sales Rise Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.